An Inside Look: The Flu

Pre-Viewing Prompt

• Instructor’s guiding questions before the film:

  • "Discuss what you already know about viruses. Are they cells? How are they transmitted? What kinds of infections do they cause?"

  • Advice while watching: pay attention to how the virus affects the body and how the immune system responds.

Scene-Setting & Characters

• Central human subject: Holly Jones, a healthy young woman and aspiring singer.

• Environment that sparks infection: crowded elevator; a stranger’s sneeze acts as the initiating event.

• Pathogen featured: Influenza B virus (a common subtype of seasonal flu).

Transmission Event

• Sneeze physics:

  • Exits mouth at $40$ mph (≈ $64.4\ \text{km/h}$).

  • Releases about $100,000$ mucus droplets, each a potential vehicle for microbes.

• Survival pressure:

  • Cold, dry elevator air kills most microbes “within minutes.”

  • To persist, they must find a new human host rapidly.

First Line of Defense – Nasal Barriers

• Nasal hairs (vibrissae): physical filter; trap almost every inhaled particle.

• Mucus layer:

  • Sticky medium capturing pathogens.

  • Contains enzymes (e.g., lysozyme) that dissolve bacteria.

• Outcome: All bacteria perish; only one “spiky” influenza virus particle survives and is inhaled deeper.

Viral Identity & Target

• Influenza B characteristics:

  • Enveloped RNA virus studded with protein spikes (hemagglutinin & neuraminidase) used for cell docking.

  • Requires ciliated epithelial cells lining the throat to replicate.

Journey Through Nasal Passages

• Nasal architecture (twists, turns, mucus rivers) is designed to drag invaders toward the stomach for destruction.

• Holly’s own inhalations repeatedly dislodge the virus, pulling it ever closer to the pharynx.

• Against odds, it reaches the throat—the key replication site.

Cellular Invasion Mechanics

• Human cells communicate via membrane receptor proteins.

• Viral spike mimics a messenger protein, docks with the correct receptor, and tricks the cell into endocytosis (engulfment).

• First stage complete: virus is now inside a host cell.

Intracellular Takeover & Replication

• Timeline: $7$ hours post-exposure, Holly feels fine.

• Virus commandeers host ribosomes & polymerases:

  • Shifts production from host proteins to viral components.

  • A single infected cell churns out $10,000$ daughter virions.

  • Replication chain reaction — each new virus infects more cells.

• After $2$ hours of active replication, about $5,000$ throat cells are infected; soon balloons to $500,000$.

Innate Immune Counter-Strike: Natural Killer (NK) Cells

• NK cells patrol tissues for abnormal protein signatures.

• Mode of action:

  • Perforin & granzyme “poison spray” that ruptures infected cells.

  • Collateral damage: numerous healthy throat epithelial cells also killed.

• Limitation: nonspecific and crudely destructive; can slow but not stop viral spread.

Debris Management – Macrophages & Cilia

• Dead-cell fragments risk blocking airways.

• Macrophages:

  • Engulf debris (“professional scavengers”).

  • Release interleukins that modulate broader immune actions.

• Cilia on epithelial cells beat debris toward the esophagus for swallowing.

Symptom Genesis – Why Holly Feels Sick

• Sore, swollen throat = result of immune collateral damage, not direct viral cytotoxicity.

• Interleukins (“chemical smoke signals”):

  • Enter bloodstream; recruit more immune cells.

  • Render peripheral nerves hypersensitive → widespread body aches.

• Biological purpose: force rest & energy conservation.

Systemic Response – Fever & Metabolic Shifts

• Hypothalamic thermostat reset by interleukins:

  • Set-point rises above $98.6^{\circ}\mathrm{F}$ ($37^{\circ}\mathrm{C}$).

  • Shivering chills despite measured warmth = body generating heat to reach new set-point.

• Effects of mild-moderate fever:

  • Viral replication efficiency drops.

  • Hematopoiesis speeds up → more immune cell production.

  • Ancillary observation: hair & nail growth accelerate ≈ $20\%$.

• High fever risk acknowledged but moderate fever beneficial; painkillers could lower fever and aid virus.

The Turning Point – Need for Adaptive Immunity

• NK cells overwhelmed; virus still prolific.

• Body seeks a specific weapon: adaptive immunity (T & B lymphocytes).

Antigen Presentation – Dendritic Cells (DCs)

• DCs in throat gather viral antigens (spike proteins) and migrate via lymphatics.

• Wear antigens like badges to scan lymph nodes for matching lymphocytes.

Lymph Node Drama – Clonal Selection Theory in Action

• Lymph node houses ≈ $10^{12}$ distinct lymphocytes (T & B cells).

• Probability puzzle: exactly one T cell + one B cell match influenza B epitopes.

• When DC contacts the correct T helper (CD4⁺) cell:

  • T cell activates → rapid clonal expansion (thousands of identical fighters).

  • Node swelling & pain = physical sign of rampant division.

Effector T Cells – Surgical Strike

• Activated Cytotoxic T lymphocytes (CTLs) home back to throat.

• Precisely induce apoptosis in infected cells, sparing neighbors.

• Symptoms witnessed:

  • Productive cough: cilia damaged; coughing required to expel debris.

B Cells & Antibody Arsenal

• Matched B cell also clonally expands but stays in lymphoid tissue.

• Differentiates into plasma cells secreting millions of antibodies:

  • Y-shaped proteins that bind virus spikes with high specificity.

  • Antibody-coated virions become neutralized (cannot attach to receptors).

• Dual pincer effect:

  • CTLs kill intracellular infection.

  • Antibodies mop up free-floating particles.

Resolution & Memory

• Battle lasts roughly $7$ days before virus eradicated.

• Damaged epithelium regenerating; Holly’s clinical recovery starts.

• Most effector cells die (apoptosis). A subset becomes Memory T & B cells:

  • Provide rapid secondary response on re-exposure (adaptive immunity’s hallmark).

Viral Counter-Measure – Antigenic Drift

• Influenza B’s evolutionary trick: mutation of spike proteins so memory cells may no longer recognize future strains.

• Explains why one can catch flu repeatedly and why vaccines must be updated annually.

Post-Viewing Discussion Topics (from program prompts)

• Vaccines:

  • Principle: introduce harmless antigenic material → provoke memory cell formation without causing disease.

  • Challenge with flu/common cold: rapid mutation (antigenic drift & shift) makes it hard to predict next season’s dominant strain.

• Eradication Scenarios:

  • If every human were perfectly immunized against all circulating variants, virus would have no host → potential extinction.

  • Practical barriers: mutation, animal reservoirs (e.g., avian, swine flu), incomplete global coverage.

Creative Classroom Activity Suggestion

• Write & stage a play illustrating the immunological battle:

  • Cast of characters: virus, nasal hairs, mucus, NK cells, macrophages, dendritic cell, T cell, B cell, antibodies, memory cells.

  • Costumes: spiky spheres for viruses, capes for dendritic “messengers,” etc.

  • Set design: transform stage areas into “elevator,” “throat battlefield,” and “lymph node command center.”

Real-World Connections & Ethical Notes

• Flu seasonality, public-health messaging on cough etiquette & vaccination.

• Impact of antipyretic overuse (fever suppression) on illness duration.

• Responsibly managing antibiotics: useless against viruses but overprescribed for flu-like symptoms → antibiotic resistance.

Numerical & Scientific References (Quick List)

• Sneeze velocity: $40$ mph.

• Droplets expelled: $100,000$.

• Viral output from one cell: $10,000$ virions.

• Initial infected cells after $2$ h: $5,000$ → later $500,000$.

• Normal body temperature: $98.6^{\circ}\text{F}$.

• Fever-driven growth rate of hair/nails: $+20\%$.

• Lymphocyte pool: $10^{12}$.

• Battle duration: ≈ $7$ days.

Key Take-Home Messages

• Influenza virus is not a cell; it is an acellular infectious particle requiring host machinery.

• Innate immunity buys time; adaptive immunity wins wars via specificity & memory.

• Symptoms often stem from our own defenses, not from direct viral damage.

• Vaccination leverages memory cell formation but must keep pace with viral mutation.